• About us
• Contact

Advertisement

Organisation › Details

Eckert & Ziegler SE

With sales of €120 million and 620 employees, the Eckert & Ziegler Group (ISIN DE0005659700) is one of the world's largest providers of components based on isotope technology for radiation therapy and nuclear medicine. *

 

	Start	2024-07-03 renamed
	Predecessor	Eckert & Ziegler Strahlen- und Medizintechnik AG
	Industry	medical device
	Street	10 Robert-Rössle-Str.
	City	13125 Berlin
		Address record changed: 2024-07-03
Basic data	Employees	F: 1,001 to 5,000 (2023-12-31)
	Currency	EUR
	Annual sales	246,092,000 (revenue, consolidate, continuing operations (2023) 2023-12-31)
	Profit	26,768,000 (2023-12-31)
	Cash	67,998,000 (2023-12-31)
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for Eckert & Ziegler (Group)

• [1] Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin....
• [2] Eckert & Ziegler SE. (1/13/25). "Press Release: Eckert & Ziegler and GlyTherix Extend Collaboration with Actinium-225 Supply Agreement". Berlin & Sydney....
• [3] Eckert & Ziegler SE. (12/13/24). "Press Release: Eckert & Ziegler Submits GalliaPharm for Approval by Japan’s Health Authority MHLW". Berlin....
• [4] Eckert & Ziegler AG. (11/14/23). "Press Release: Eckert & Ziegler Establishes German-Chinese Joint Venture with DC Pharma for the Production of Radioisotopes". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.